120 related articles for article (PubMed ID: 32053505)
1. Clinical characteristics and risk factors for shock and death from E. coli bacteremia in pediatric hematological patients.
Wang H; Liu J; Huang Z; Tao X; Li J; Hu Y; Dou Q; Zou M; Yan Q; Liu WE
J Infect Dev Ctries; 2019 May; 13(5):365-373. PubMed ID: 32053505
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.
Ma J; Li N; Liu Y; Wang C; Liu X; Chen S; Xie X; Gan S; Wang M; Cao W; Wang F; Liu Y; Wan D; Sun L; Sun H
Medicine (Baltimore); 2017 May; 96(21):e6959. PubMed ID: 28538389
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study on Escherichia coli bacteremia in immunocompromised patients: Microbiological features, clinical characteristics, and risk factors for shock and death.
Tao X; Wang H; Min C; Yu T; Luo Y; Li J; Hu Y; Yan Q; Liu WE; Zou M
J Clin Lab Anal; 2020 Aug; 34(8):e23319. PubMed ID: 32267010
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
Liu J; Wang H; Huang Z; Tao X; Li J; Hu Y; Dou Q; Zou M
J Infect Dev Ctries; 2019 May; 13(5):357-364. PubMed ID: 32053504
[TBL] [Abstract][Full Text] [Related]
7. [Antibiotic Resistance and Risk Factors for Mortality of Blood Stream Infections (BSIs) with
Zhang WL; Huang J; Wu SY; Liu Y; Long F; Xiao YL; Xie Y; He C; Kang M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):133-135. PubMed ID: 29737104
[TBL] [Abstract][Full Text] [Related]
8. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
9. Bacteremias caused by Escherichia coli in cancer patients - analysis of 65 episodes.
Krcmery V; Spanik S; Mrazova M; Trupl J; Grausova S; Grey E; Kukuckova E; Sulcova M; Krupova I; Koren P
Int J Infect Dis; 2002 Mar; 6(1):69-73. PubMed ID: 12044306
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
[TBL] [Abstract][Full Text] [Related]
11. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.
Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Nadali G; Busca A; Del Principe MI; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;
PLoS One; 2019; 14(10):e0224465. PubMed ID: 31661507
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.
Kang CI; Wi YM; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
Scand J Infect Dis; 2013 Jul; 45(7):519-25. PubMed ID: 23509913
[TBL] [Abstract][Full Text] [Related]
14. Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study.
MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
BMC Infect Dis; 2021 Jun; 21(1):606. PubMed ID: 34172003
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.
Qiao B; Wu J; Wan Q; Zhang S; Ye Q
BMC Infect Dis; 2017 Feb; 17(1):171. PubMed ID: 28241746
[TBL] [Abstract][Full Text] [Related]
16. Predictors of shock and mortality in solid organ transplant recipients with bacteremia caused by non-lactose-fermenting gram-negative bacilli.
Wan Q; Luo A; Ye Q; Liu S; Zhou J
Infect Dis (Lond); 2016; 48(1):32-9. PubMed ID: 26329287
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.
Namikawa H; Yamada K; Fujimoto H; Oinuma KI; Tochino Y; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
Intern Med; 2017; 56(14):1807-1815. PubMed ID: 28717075
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China.
Wang S; Zhao SY; Xiao SZ; Gu FF; Liu QZ; Tang J; Guo XK; Ni YX; Han LZ
PLoS One; 2016; 11(1):e0147740. PubMed ID: 26824702
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant Escherichia coli bacteremia in cancer patients.
Vigil KJ; Adachi JA; Aboufaycal H; Hachem RY; Reitzel RA; Jiang Y; Tarrand JJ; Chemaly RF; Bodey GP; Rolston KV; Raad I
Am J Infect Control; 2009 Nov; 37(9):741-5. PubMed ID: 19487050
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
